Keyword Connections

•  Charles Hong

•  J Greg Terry

•  Xiao Shu

Resources

• No matching connections

Communities

• No matching connections

Publications

• Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome).
  Vidaillet HJ, Pressley JC, Henke E, Harrell FE, German LD
  (1987) N Engl J Med 317: 65-9
• A rare variant in MYH6 is associated with high risk of sick sinus syndrome.
  Holm H, Gudbjartsson DF, Sulem P, Masson G, Helgadottir HT, Zanon C, Magnusson OT, Helgason A, Saemundsdottir J, Gylfason A, Stefansdottir H, Gretarsdottir S, Matthiasson SE, Thorgeirsson GM, Jonasdottir A, Sigurdsson A, Stefansson H, Werge T, Rafnar T, Kiemeney LA, Parvez B, Muhammad R, Roden DM, Darbar D, Thorleifsson G, Walters GB, Kong A, Thorsteinsdottir U, Arnar DO, Stefansson K
  (2011) Nat Genet 43: 316-20
• Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16.
  Cordell HJ, Bentham J, Topf A, Zelenika D, Heath S, Mamasoula C, Cosgrove C, Blue G, Granados-Riveron J, Setchfield K, Thornborough C, Breckpot J, Soemedi R, Martin R, Rahman TJ, Hall D, van Engelen K, Moorman AF, Zwinderman AH, Barnett P, Koopmann TT, Adriaens ME, Varro A, George AL, dos Remedios C, Bishopric NH, Bezzina CR, O'Sullivan J, Gewillig M, Bu'Lock FA, Winlaw D, Bhattacharya S, Devriendt K, Brook JD, Mulder BJ, Mital S, Postma AV, Lathrop GM, Farrall M, Goodship JA, Keavney BD
  (2013) Nat Genet 45: 822-4
• Evaluating the yield of medical tests.
  Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA
  (1982) JAMA 247: 2543-6
• Immune checkpoint inhibitors and cardiovascular toxicity.
  Lyon AR, Yousaf N, Battisti NML, Moslehi J, Larkin J
  (2018) Lancet Oncol 19: e447-e458
• Late cardiac effects of cancer treatment.
  Lenihan DJ, Cardinale DM
  (2012) J Clin Oncol 30: 3657-64
• Reply to R. Steiner et al.
  Lenihan D, Cardinale D
  (2013) J Clin Oncol 31: 1380
• Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
  Tebbi CK, London WB, Friedman D, Villaluna D, De Alarcon PA, Constine LS, Mendenhall NP, Sposto R, Chauvenet A, Schwartz CL
  (2007) J Clin Oncol 25: 493-500
• Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.
  Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, Dent S, Douglas PS, Durand JB, Ewer M, Fabian C, Hudson M, Jessup M, Jones LW, Ky B, Mayer EL, Moslehi J, Oeffinger K, Ray K, Ruddy K, Lenihan D
  (2017) J Clin Oncol 35: 893-911
• Anthracycline cardiotoxicity: from bench to bedside.
  Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB
  (2008) J Clin Oncol 26: 3777-84
• Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.
  Cornell RF, Ky B, Weiss BM, Dahm CN, Gupta DK, Du L, Carver JR, Cohen AD, Engelhardt BG, Garfall AL, Goodman SA, Harrell SL, Kassim AA, Jadhav T, Jagasia M, Moslehi J, O'Quinn R, Savona MR, Slosky D, Smith A, Stadtmauer EA, Vogl DT, Waxman A, Lenihan D
  (2019) J Clin Oncol 37: 1946-1955
• Pharmacogenomics: personalizing pediatric heart transplantation.
  Van Driest SL, Webber SA
  (2015) Circulation 131: 503-12
• The effect of cardiac hypertrophy on the coronary collateral circulation.
  Harrison DG, Barnes DH, Hiratzka LF, Eastham CL, Kerber RE, Marcus ML
  (1985) Circulation 71: 1135-45
• Cardiovascular effects of noncardiovascular drugs.
  Raj SR, Stein CM, Saavedra PJ, Roden DM
  (2009) Circulation 120: 1123-32
• AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society.
  Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, Epstein AE, Friedman P, Goldberger J, Heidenreich PA, Klein GJ, Knight BP, Morillo CA, Myerburg RJ, Sila CA, American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, Quality of Care and Outcomes Research Interdisciplinary Working Group, American College of Cardiology Foundation, Heart Rhythm Society, American Autonomic Society
  (2006) Circulation 113: 316-27
• Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.
  Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
  (2018) Circulation 137: e67-e492
• Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children.
  Almond CS, Morales DL, Blackstone EH, Turrentine MW, Imamura M, Massicotte MP, Jordan LC, Devaney EJ, Ravishankar C, Kanter KR, Holman W, Kroslowitz R, Tjossem C, Thuita L, Cohen GA, Buchholz H, St Louis JD, Nguyen K, Niebler RA, Walters HL, Reemtsen B, Wearden PD, Reinhartz O, Guleserian KJ, Mitchell MB, Bleiweis MS, Canter CE, Humpl T
  (2013) Circulation 127: 1702-11
• Noninvasive, in utero imaging of mouse embryonic heart development with 40-MHz echocardiography.
  Srinivasan S, Baldwin HS, Aristizabal O, Kwee L, Labow M, Artman M, Turnbull DH
  (1998) Circulation 98: 912-8
• Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
  Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
  (2020) Circulation 141: e139-e596
• Cardiology patient page. Breast cancer chemotherapy and your heart.
  Unitt C, Montazeri K, Tolaney S, Moslehi J
  (2014) Circulation 129: e680-2
• Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
  Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
  (2019) Circulation 139: e56-e528
• ABCDE steps to prevent heart disease in breast cancer survivors.
  Montazeri K, Unitt C, Foody JM, Harris JR, Partridge AH, Moslehi J
  (2014) Circulation 130: e157-9
• Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease.
  Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J
  (2014) Eur Heart J 35: 612-23
• Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease.
  Denney WD, Kemp WE, Anthony LB, Oates JA, Byrd BF
  (1998) J Am Coll Cardiol 32: 1017-22
• AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society.
  Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, Epstein AE, Friedman P, Goldberger J, Heidenreich PA, Klein GJ, Knight BP, Morillo CA, Myerburg RJ, Sila CA, American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, Quality of Care and Outcomes Research Interdisciplinary Working Group, American College of Cardiology Foundation, Heart Rhythm Society
  (2006) J Am Coll Cardiol 47: 473-84
• Insights into (the interstitium of) degenerative aortic valve disease.
  Merryman WD
  (2008) J Am Coll Cardiol 51: 1415; author reply 1416
• Lack of cardiac manifestations among patients with previously treated Lyme disease.
  Sangha O, Phillips CB, Fleischmann KE, Wang TJ, Fossel AH, Lew R, Liang MH, Shadick NA
  (1998) Ann Intern Med 128: 346-53
• Oxidized CaMKII: a "heart stopper" for the sinus node?
  Huke S, Knollmann BC
  (2011) J Clin Invest 121: 2975-7
• Potential drug targets for calcific aortic valve disease.
  Hutcheson JD, Aikawa E, Merryman WD
  (2014) Nat Rev Cardiol 11: 218-31
• Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors.
  Becker BN, Himmelfarb J, Henrich WL, Hakim RM
  (1997) J Am Soc Nephrol 8: 475-86
• Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt.
  Lea WB, Kwak ES, Luther JM, Fowler SM, Wang Z, Ma J, Fogo AB, Brown NJ
  (2009) Kidney Int 75: 936-44
• Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
  Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ
  (2012) Kidney Int 82: 643-51
• Serotonin receptors and heart valve disease--it was meant 2B.
  Hutcheson JD, Setola V, Roth BL, Merryman WD
  (2011) Pharmacol Ther 132: 146-57
• Diabetes TV news coverage lags behind.
  Miller ST, Campbell MN, Pichert JW
  (2002) Diabetes Care 25: 607
• Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
  Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
  (2020) Ann Oncol 31: 171-190
• Do fish oil omega-3 fatty acids enhance antioxidant capacity and mitochondrial fatty acid oxidation in human atrial myocardium via PPARγ activation?
  Anderson EJ, Thayne KA, Harris M, Shaikh SR, Darden TM, Lark DS, Williams JM, Chitwood WR, Kypson AP, Rodriguez E
  (2014) Antioxid Redox Signal 21: 1156-63
• Clinical and molecular pharmacologic characteristics of adenosine-induced vasodilation.
  Biaggioni I
  (2004) Clin Pharmacol Ther 75: 137-9
• Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.
  Yutzey KE, Demer LL, Body SC, Huggins GS, Towler DA, Giachelli CM, Hofmann-Bowman MA, Mortlock DP, Rogers MB, Sadeghi MM, Aikawa E
  (2014) Arterioscler Thromb Vasc Biol 34: 2387-93
• Cadherin-11 regulates cell-cell tension necessary for calcific nodule formation by valvular myofibroblasts.
  Hutcheson JD, Chen J, Sewell-Loftin MK, Ryzhova LM, Fisher CI, Su YR, Merryman WD
  (2013) Arterioscler Thromb Vasc Biol 33: 114-20